Free Trial

Edgewise Therapeutics (EWTX) SEC Filings & 10K Form

Edgewise Therapeutics logo
$25.67 +0.39 (+1.54%)
Closing price 04:00 PM Eastern
Extended Trading
$26.44 +0.77 (+3.00%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Edgewise Therapeutics SEC Filings

DateFilerForm TypeView
03/11/2025
3:32 PM
Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:33 PM
Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:00 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
7:05 AM
Edgewise Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
4:57 PM
Edgewise Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SCHEDULE 13G
02/14/2025
10:24 AM
Edgewise Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G
02/07/2025
3:37 PM
Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:38 PM
Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:38 PM
Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:19 PM
Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
3:20 PM
Edgewise Therapeutics (Subject)
KOCH KEVIN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
3:36 PM
Edgewise Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SCHEDULE 13G
01/28/2025
3:18 PM
Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
6:56 PM
Blaustein Robert (Reporting)
Edgewise Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
6:56 PM
Blaustein Robert (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:20 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
4:13 PM
Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:10 PM
Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
3:30 PM
Edgewise Therapeutics (Issuer)
Semigran Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
7:15 AM
Edgewise Therapeutics (Subject)
Semigran Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
4:25 PM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:22 PM
EcoR1 Capital, LLC (Filed by)
Edgewise Therapeutics (Subject)
Form SC 13G/A
11/14/2024
7:59 AM
Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
11/12/2024
8:55 AM
Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2024
7:53 AM
Edgewise Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2024
7:07 AM
Edgewise Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:00 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Edgewise Therapeutics (Subject)
Form SC 13G
10/16/2024
3:23 PM
Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:22 PM
Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:24 PM
Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:24 PM
Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:25 PM
Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:25 PM
Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:20 PM
Edgewise Therapeutics (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
09/20/2024
4:37 PM
Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:46 PM
Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:29 PM
Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
4:07 PM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:00 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:06 AM
Edgewise Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Urgent Bitcoin alert for RIGHT NOW (Ad)

Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career. During the presentation, Larry reveals a strategy every trader and investor needs to understand. He calls it “Bitcoin Skimming.”

So please… click here to watch now.
07/10/2024
9:10 AM
Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
06/12/2024
6:23 PM
Edgewise Therapeutics (Issuer)
Edris Badreddin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:25 PM
Brege Laura (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:26 PM
Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:32 PM
Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:33 PM
Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:22 PM
Edgewise Therapeutics (Issuer)
ROOT JONATHAN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:09 PM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
8:07 AM
Edgewise Therapeutics (Filer)
Form S-3ASR
05/10/2024
8:10 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:21 AM
Edgewise Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2024
7:00 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:06 AM
Edgewise Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:51 PM
Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2024
6:52 PM
Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:16 AM
Edgewise Therapeutics (Filer)
Form DEFA14A
05/07/2024
8:14 AM
Edgewise Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:26 PM
Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:27 PM
Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:28 PM
Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:29 PM
Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:30 PM
Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:31 PM
Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:EWTX) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners